Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update

被引：78
|
作者：
Ardissino, Gianluigi [1 ]
Possenti, Ilaria [1 ]
Tel, Francesca [1 ]
Testa, Sara [1 ]
Salardi, Stefania [1 ]
Ladisa, Vito [1 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr HUS Control, Prevent & Management, Milan, Italy
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 66卷 / 01期
关键词：
D O I：
10.1053/j.ajkd.2015.04.010
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 173
页数：3
相关论文
共 50 条
  • [1] In Reply to 'Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome'
    Ardissino, Gianluigi
    Possenti, Ilaria
    Tel, Francesca
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (02) : 342 - 343
  • [2] Eculizumab treatment of atypical hemolytic uremic syndrome
    Kaplan, Bernard S.
    Ruebner, Rebecca L.
    Copelovitch, Lawrence
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (02): : 167 - 176
  • [3] Discontinuation treatment with eculizumab in patients with hemolytic uremic syndrome
    Mendizabal, S.
    Arjona, E.
    Rodriguez de Cordoba, S.
    Martin, J.
    PEDIATRIC NEPHROLOGY, 2019, 34 (05) : 746 - 746
  • [4] Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases
    Ardissino, Gianluigi
    Testa, Sara
    Possenti, Ilaria
    Tel, Francesca
    Paglialonga, Fabio
    Salardi, Stefania
    Tedeschi, Silvana
    Belingheri, Mirco
    Cugno, Massimo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (04) : 633 - 637
  • [5] SUCCESS OF ECULIZUMAB IN THE TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Kantar, Asli
    Gulleroglu, Kaan
    Bayrakci, Umut
    Ozkaya, Ozan
    Ozcan, Ebru
    Baskin, Esra
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1572 - 1572
  • [6] The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
    Santos, Mariana S.
    Ventura, Sofia
    Alves, Abel
    Cabral, Raquel
    Henriques, Manuela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [7] Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants
    Ariceta, Gema
    Arrizabalaga, Beatriz
    Aguirre, Mireia
    Morteruel, Elvira
    Lopez-Trascasa, Margarita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (05) : 707 - 710
  • [8] Success of eculizumab in the treatment of atypical hemolytic uremic syndrome
    Esra Baskin
    Kaan Gulleroglu
    Asli Kantar
    Umut Bayrakci
    Ozan Ozkaya
    Pediatric Nephrology, 2015, 30 : 783 - 789
  • [9] Success of eculizumab in the treatment of atypical hemolytic uremic syndrome
    Baskin, Esra
    Gulleroglu, Kaan
    Kantar, Asli
    Bayrakci, Umut
    Ozkaya, Ozan
    PEDIATRIC NEPHROLOGY, 2015, 30 (05) : 783 - 789
  • [10] Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH
    Habbig, Sandra
    Bergmann, Carsten
    Weber, Lutz T.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (03) : 532 - 533
12345